Not_yet_recruitingNANCT07599956

Artificial Intelligence to Scale Early Rheumatic Heart Disease Detection

Sponsor: Children's Hospital Medical Center, Cincinnati

Trial Details

Condition	Rheumatic Heart Disease
Intervention	AI assisted echocardiography
Phase	NA
Status	Not_yet_recruiting
Participants	62
Est. Completion	1 June 2028
Last Updated	27 May 2026

Primary Outcome

Accuracy of Provider RHD Screening

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Employed at a participating ADUNU facility * Holds a designated role in the ADUNU program as a nurse screener Exclusion Criteria: * None. The pragmatic trial design includes all eligible staff at participating facilities.

Trial Sites

Countries

Uganda

View Registry Entry

Related Analysis

AI-Assisted Echocardiography Trial Targets Rheumatic Heart Disease Screening in Uganda — Implications for Global Health Programs

A pragmatic trial in Uganda evaluates AI-assisted echocardiography for rheumatic heart disease screening by nurse practitioners. The RADAR system aims to democratise early detection in resource-limited settings where specialist cardiac expertise is scarce.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service